Print Page  Close Window

2018 News Releases

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
Ra Pharmaceuticals to Present at the 23rd Congress of the European Hematology Association

Read More

Ra Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update

Read More

Ra Pharmaceuticals to Present at the Deutsche Bank 43rd Annual Health Care Conference

Read More

Ra Pharmaceuticals Announces Presentation of RA101495 SC Phase 2 gMG Clinical Trial Design at the 70th Annual AAN Meeting

Read More

Ra Pharmaceuticals Appoints John C. King as Chief Commercial Officer

Read More

Ra Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update

Read More

Ra Pharmaceuticals to Present at the Cowen and Company 38th Annual Health Care Conference

Read More

Ra Pharmaceuticals to Present Design of RA101495 SC Phase 2 Clinical Trial in gMG at the 70th Annual AAN Meeting

Read More

Ra Pharma Supports 11th Annual Rare Disease Day® and Joins Global Movement to Raise Awareness for Rare Diseases

Read More

Ra Pharmaceuticals to Present at the RBC Capital Markets 2018 Global Healthcare Conference

Read More

Ra Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Read More

Ra Pharmaceuticals Announces Proposed Public Offering of Common Stock

Read More

Ra Pharmaceuticals Announces Completion of Dosing in Phase 2 Program of RA101495 SC in Paroxysmal Nocturnal Hemoglobinuria

Read More

Ra Pharmaceuticals Initiates Dosing in Phase 1b Pharmacokinetic Study Evaluating RA101495 SC in Patients with Renal Impairment

Read More